Biotinoyl Tripeptide-1 Powder, 1 g, is a cosmetic peptide raw material (INCI: Biotinoyl Tripeptide-1) for brands developing scalp, hair, brow and lash-care products. The dry powder format lets you pick your own carrier and control exactly how much peptide enters each batch. One gram is a compact pack for lab trials and small premium runs.
What This Peptide Powder Is
Biotinoyl Tripeptide-1 is supplied here as a concentrated powder rather than a pre-diluted solution. It is an ingredient for product development, not a ready lash serum, and the powder itself should not be applied to skin, lashes or the eye area. Assay, appearance, solubility, processing conditions and the recommended input level are batch-specific and come from the documentation for the exact lot you receive.
Why Choose the Powder Format
Full control over the carrier
Because nothing is pre-dissolved, you decide which solvent system, texture and packaging suit your concept, whether a watery scalp tonic or a gel for brows.
Compact storage and shipping
A 1 g pack takes almost no space and fits neatly into a development kit next to other actives.
Clear distinction from solutions
Powder and liquid peptides are not interchangeable gram for gram. Use rates written for a diluted solution do not apply directly to this concentrate.
Applications
Typical projects include leave-on scalp serums, hair tonics, brow gels and lash-care serums where a peptide is part of the concept. Explore more concentrates in our peptide powders category, or compare with liquid options in the broader active ingredients section. For lash and brow products, some developers also review Myristoyl Pentapeptide-17 powder, 1 g as a companion peptide.
How to Use
Read the technical documentation supplied with the batch before weighing anything. It defines the solvent, pH window, processing temperature and input level. Use an analytical balance, as quantities for a 1 g pack are small. Dissolve the powder fully in the chosen carrier before adding it to the main batch, then test the finished product for stability, preservation and compatibility with its packaging. For more detail, read our guide Myristoyl Pentapeptide-17 vs Biotinoyl Tripeptide-1.
Compatibility
Peptides are often combined with humectant gels. A ready hyaluronic acid gel can serve as a smooth base for brow and lash gels. Confirm compatibility with every other ingredient in a small pilot sample, because pH and preservatives can affect peptide stability.
Characteristics
INCI: Biotinoyl Tripeptide-1. Form: powder. Net weight: 1 g. Intended use: cosmetic ingredient for product development. A verified batch COA has not yet been uploaded to the listing; TDS, SDS and specification documents will be added as they are verified, and you can request available technical information before ordering.
Recipe: Brow Gel Trial Base (50 g)
Ingredients: 20 g hyaluronic acid gel and 30 g distilled water. Weigh the water into a beaker, then fold in the hyaluronic acid gel with slow stirring to avoid air bubbles. Biotinoyl Tripeptide-1 is added to this base only after it has been dissolved as the batch technical sheet directs, and at the level that sheet states; the card gives no use level, so no amount is shown here. Fill into a mascara-style tube. A base intended for storage also needs a preservation system and stability checks before it becomes a finished product.
Storage
Follow the storage conditions in the batch documentation.
Add a 1 g pack to your next order and start developing a peptide scalp or lash concept with full control over the dose.
FAQ
Can I apply this powder directly to my lashes?
No. It is a raw ingredient that must first be incorporated into a finished, tested product.
How much powder does the pack contain?
Each pack contains 1 g of Biotinoyl Tripeptide-1 powder.
What input level should I use?
Take the level, solvent and pH from the technical documentation for the supplied batch.
Are batch documents available?
Contact BeautyLabPro before ordering to request the available COA and technical information.










Reviews
There are no reviews yet.